1 Not fully satisfied at final follow up |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
2 Decreased range of motion |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
2.1 At 1 week follow up |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2.2 At 3 to 6 weeks follow up |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2.3 At final follow up |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
3 Loss of grip strength |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
3.1 At 3 to 6 weeks follow up |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
3.2 At final follow up |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |